Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (161-170 of 825) with videos related to

Pageof 83
Sort By:
Transplantation Proceedings|March 1, 1977
Murine minor-lymphocyte-stimulating locus defines B-cell subclass whose expression is dependent on genes on X chromosomeI Scher, A Ahmed, S Sharrow, et al.
Current Opinion in Neurology|May 14, 2005
Comorbidity of migraineAnn I Scher, Marcelo E Bigal, Richard B Lipton
Urologic Oncology|March 10, 2015
Biomarker development in the context of urologic cancersGary J Kelloff, Caroline C Sigman, Howard I Scher
Current Treatment Options in Oncology|April 25, 2012
Therapeutic strategies for bone metastases and their clinical sequelae in prostate cancerKaren A Autio, Howard I Scher, Michael J Morris
Headache|January 11, 2008
Risk factors for headache chronificationAnn I Scher, Lynn A Midgette, Richard B Lipton
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1976
Cellular mechanism of endotoxin unresponsiveness in C3H/HeJ miceL M Glode, I Scher, B Osborne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1981
Altered idiotype response to phosphocholine in mice bearing an x-linked immune defectJ J Kenny, G Guelde, J L Claflin, et al.
Journal of Immunogenetics|June 1, 1977
Studies on non-H-2 linked lymphocyte activating determinants. I. Description of the cell type bearing the Mls productA Ahmed, I Scher, A H Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1981
Activation of mouse lymphocytes by anti-immunoglobulin. III. Analysis of responding B lymphocytes by flow cytometry and cell sortingD G Sieckmann, R Habbersett, I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practiceHoward I Scher, Michael J Morris, Ethan Basch, et al.
Pageof 83

Showing results (161-170 of 825) with videos related to

Sort By:
Pageof 83
Transplantation Proceedings|March 1, 1977
Murine minor-lymphocyte-stimulating locus defines B-cell subclass whose expression is dependent on genes on X chromosomeI Scher, A Ahmed, S Sharrow, et al.
Current Opinion in Neurology|May 14, 2005
Comorbidity of migraineAnn I Scher, Marcelo E Bigal, Richard B Lipton
Urologic Oncology|March 10, 2015
Biomarker development in the context of urologic cancersGary J Kelloff, Caroline C Sigman, Howard I Scher
Current Treatment Options in Oncology|April 25, 2012
Therapeutic strategies for bone metastases and their clinical sequelae in prostate cancerKaren A Autio, Howard I Scher, Michael J Morris
Headache|January 11, 2008
Risk factors for headache chronificationAnn I Scher, Lynn A Midgette, Richard B Lipton
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1976
Cellular mechanism of endotoxin unresponsiveness in C3H/HeJ miceL M Glode, I Scher, B Osborne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1981
Altered idiotype response to phosphocholine in mice bearing an x-linked immune defectJ J Kenny, G Guelde, J L Claflin, et al.
Journal of Immunogenetics|June 1, 1977
Studies on non-H-2 linked lymphocyte activating determinants. I. Description of the cell type bearing the Mls productA Ahmed, I Scher, A H Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1981
Activation of mouse lymphocytes by anti-immunoglobulin. III. Analysis of responding B lymphocytes by flow cytometry and cell sortingD G Sieckmann, R Habbersett, I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practiceHoward I Scher, Michael J Morris, Ethan Basch, et al.
Pageof 83